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Abstract The present study showed that corticosterone (B)
could induce a rapid activation of p38 and c-Jun NH2-terminal
protein kinase (JNK) in PC12 cells. The dose^response and
time^response curves were bell-shaped with maximal activation
at 1039 M and at 15 min. RU38486 had no effect, and bovine
serum albumin-coupled B could induce the activation. Genistein
failed to block the phosphorylation, suggesting the pathway was
not involved in tyrosine kinase activity. Phorbol 12-myristate 13-
acetate could mimic, while Go«6976 could abolish the actions.
These results demonstrated that B might act via a putative
membrane receptor to activate p38 and JNK rapidly through a
protein kinase C-dependent pathway. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Steroid hormones exert important e¡ects through their in-
tracellular receptors, which act as ligand-dependent transcrip-
tion factors to in£uence gene expression. These genomic ef-
fects have been well known for decades, but fail to explain the
rapid e¡ects occurring in minutes or seconds. The non-ge-
nomic mechanism(s) underlying the rapid e¡ects are poorly
understood, but may play a pivotal role in physiological pro-
cesses as they regulate ion channels, second messengers and
protein kinases, such as protein kinase A (PKA) and/or pro-
tein kinase C (PKC) [19]. Mitogen-activated protein kinases
(MAPKs) are known as Ser/Thr protein kinases involved in
many important cellular processes, such as cell growth, di¡er-
entiation, survival, apoptosis and cytokine production, etc.
They are expressed in all eukaryotic cells and activated by
diverse stimuli. Three well-characterized MAPK subfamilies
in mammalian cells are the extracellular signal-regulated ki-
nases (Erks), the p38 MAPK and the c-Jun NH2-terminal
protein kinase (JNK). While growth factors elicit the activa-
tion of Erks, stress responses and in£ammatory mediators
lead to the activation of p38 and JNK. Recently, di¡erential
e¡ects of 17L-estradiol on MAPK pathways in rat cardiomyo-
cytes were reported [1]. To elucidate the signaling pathways
involved in the rapid e¡ect of glucocorticoid we have also
investigated the in£uence of corticosterone (B) on Erk1/2 in
PC12 cells [21]. Here we examined the e¡ect of B on rapid
phosphorylation of p38 and JNK MAPKs and its underlying
mechanism. The results showed that B could induce a rapid
activation of p38 and JNK MAPKs through a PKC-depen-
dent pathway.
2. Materials and methods
2.1. Materials
Corticosterone 21-sulfate, bovine serum albumin (BSA; fatty acid-
free), corticosterone 21-hemisuccinate, nerve growth factor (NGF),
genistein and RU38486 were purchased from Sigma (St. Louis, MO,
USA). Phorbol 12-myristate 13-acetate (PMA) and Go«6976 were from
Calbiochem (La Jolla, CA, USA). Phospho-p38 MAPK (Thr180/
Tyr182) antibody (#9210) that detects Thr180- and Tyr182-phosphor-
ylated p38 MAPK (dual-phosphorylated), p38 MAPK antibody
(#9210) that recognizes total p38 MAPK (phosphorylation state-in-
dependent) protein levels, phospho-SAPK/JNK (Thr183/Tyr185) anti-
body (#9251S) that detects SAPK/JNK only when activated by phos-
phorylation at Thr183 and Tyr185 and SAPK/JNK MAPK antibody
(#9252) that recognizes total SAPK/JNK (phosphorylation state-in-
dependent) protein levels were purchased from New England Biolabs
(Beverly, MA, USA). All other chemicals used were of analytical
grade.
2.2. Cell culture
PC12 cells were the kind gift of Dr. K. Kuba (Department of
Physiology, Saga Medical School, Saga, Japan). Cells were grown in
Dulbecco’s modi¢ed Eagle’s medium (DMEM) with high glucose
(Gibco BRL, Grand Island, NY, USA) supplied with 10% fetal bo-
vine serum and 5% heat-inactivated horse serum and incubated in a
humidi¢ed atmosphere containing 5% CO2 in the air at 37‡C. Flasks
used to culture PC12 cells were pre-coated with collagen to facilitate
cell adherence to the surface of the substrate.
2.3. Western blot analysis
PC12 cells were grown to sub-con£uence in tissue culture £asks,
serum-starved for 12 h in phenol red-free DMEM, and stimulated
with drugs at 37‡C for the indicated time. After drug treatment, cells
were washed twice with ice-cold phosphate-bu¡ered saline, pH 7.4,
suspended in sample bu¡er (62.5 mM Tris^HCl, pH 6.8, 2% (w/v)
sodium dodecyl sulfate (SDS), 10% glycerol, 50 mM dithiothreitol,
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0.1% (w/v) bromophenol blue), sonicated for 15 s on ice, and heated
at 100‡C for 5 min. Then a 10% SDS^polyacrylamide gel electropho-
resis was performed and proteins were transferred electrophoretically
to a nitrocellulose membrane. The membrane was blocked in Tris-
bu¡ered saline containing 5% non-fat dry milk and 0.1% Tween 20.
Immunoblotting was performed with anti-phospho-p38 (1:1000) or
anti-phospho-JNK (1:1000) MAPK antibody overnight and with a
secondary antibody conjugated to horseradish peroxidase (1:1000)
for 1 h. The enhanced chemiluminescence light-based detection system
was used to detect the peroxidase activity. Results were quanti¢ed by
densitometric scan of X-ray ¢lms using a densitometer.
2.4. Statistical analysis
At least three independent experiments were carried out and all
data are expressed as the mean þ S.E.M. of all determinations. The
statistical signi¢cance of the results was assessed by Student’s t-test.
Di¡erences were considered signi¢cant at P6 0.05 levels.
3. Results
To investigate the signal transduction pathway involved in
the rapid, non-genomic e¡ects of glucocorticoid in PC12 cells
we examined the in£uence of B on p38 and JNK MAPKs.
Immunoblotting with phospho-speci¢c antibodies selective
against the activated, phosphorylated MAPKs was performed.
In the absence of B, the levels of phosphorylated p38 and
JNK were low. Stimulation of PC12 cells with B (10311^
1037 M) for 15 min induced an increase of phosphorylated
p38 and JNK with the maximal activation at the 1039 M level
(Fig. 1). Treatment of B (1039 M) for 5^120 min also led to a
rapid and transient activation of p38 and JNK (Fig. 2). The
signi¢cant e¡ect appeared at 5 min and with a maximum of
3.72 þ 0.7-fold and 2.98 þ 0.8-fold, respectively, at 15 min. The
dose^response and time^response curves were both bell-
shaped. Pretreatment of speci¢c p38 antagonist SB203580
(1035 M) for 15 min blocked p38 activation induced by B
and the agonist, anisomycin, could signi¢cantly activate p38
MAPK in 15 min (Fig. 3).
To further elucidate the rapid e¡ect of B in PC12 cells we
studied the e¡ect of BSA-coupled B (B-BSA), which is mem-
brane impermeable, and the glucocorticoid nuclear receptor
antagonist RU38486 on PC12 cells. Incubation with B-BSA
(1037 M) for 15 min could signi¢cantly increase the phosphor-
ylation of p38 and JNK (Fig. 4). Pretreatment with RU38486
(1036 M, 30 min) had no e¡ect on the rapid activation in-
duced by B. These results demonstrated that the rapid action
might be mediated by the B binding to its putative membrane
receptor.
Many kinds of cell surface receptor possess the ability to
phosphorylate tyrosine residue, which may lead to the phos-
phorylation of MAPKs via activation of several adapter pro-
teins. We used receptor tyrosine kinase (RTK) inhibitor, gen-
istein, to examine the involvement of RTK in the process. The
Fig. 1. Dose^response of B-stimulated p38 and JNK activation in
PC12 cells. Cells were stimulated with B (10311^1037 M) for 15 min
and the phosphorylation of p38 (parallel A upper) and JNK (paral-
lel B upper) was determined by immunoblot. Parallel A lower and
parallel B lower represent total p38 and total JNK using phospho-
independent MAPK antibody, respectively. C: Concentration curve
of B-stimulated p38 and JNK activation in PC12 cells. Quanti¢ca-
tion of p38 and JNK phosphorylation was determined by densito-
metric analysis of immunoblot. Data are the means þ S.E.M. from
three independent experiments.
Fig. 2. Time-dependent activation of p38 and JNK by B in PC12
cells. Cells were incubated with B (1039 M) for the indicated times
(5^120 min) and the phosphorylation of p38 (parallel A upper) and
JNK (parallel B upper) was determined by immunoblot. Parallel A
lower and parallel B lower represent total p38 and total JNK using
phospho-independent MAPK antibody, respectively. C: Time course
of B-stimulated p38 and JNK activation in PC12 cells. Quanti¢ca-
tion of p38 and JNK phosphorylation was determined by densito-
metric analysis of immunoblot. Data are the means þ S.E.M. from
three independent experiments.
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result showed that co-treatment with genistein (1034 M, 15
min) could completely block NGF-induced activation of p38
and JNK (Fig. 5). However, it had no e¡ect on the B-induced
rapid phosphorylation. These ¢ndings implied that the rapid,
non-genomic e¡ect of B did not involve tyrosine kinase activ-
ity.
Some recent studies showed that PKC might regulate the
MAPK pathways [12^15]. To extend our previous study [21]
we investigated the involvement of PKC in p38 and JNK
rapid activation. Western blot showed that co-treatment of
PC12 cells with the speci¢c PKC inhibitor, Go«6976 (1037
M, 15 min), completely inhibited the rapid phosphorylation
of MAPKs (Fig. 6) and PMA, a PKC activator, could mimic
the actions of B. These ¢ndings indicated that the PKC is
involved in the rapid activation of MAPKs by B.
4. Discussion
Recent evidence showed the involvement of the G protein^
PKC pathway and/or the G protein^PKA pathway in the
putative steroid membrane receptor-mediated glucocorticoid’s
rapid actions [7,19]. However, the signaling pathways in the
steroid rapid, non-genomic actions need more investigation.
Di¡erential e¡ects of 17L-estradiol on MAPK pathways in rat
cardiomyocytes were reported [1]. It is known that MAPKs
are activated by phosphorylation of threonine and tyrosine
residues by dual speci¢city MAPK kinase [20]. Our previous
work found, for the ¢rst time, that B could rapidly activate
Erk1/2 MAPK in PC12 cells [21].
The present study showed that treatment with B in PC12
cells also resulted in a rapid activation of p38 and JNK in a
dose- and time-dependent manner. The concentration-depen-
dent curve and the time-dependent curve were both bell-
shaped. However, the maximal activation of p38 and JNK
induced by B were both 1039 M within 15 min. This result
was similar to the one of Erk1/2 [21]. Though di¡erential
activation of MAPK families were reported in recent studies
[1^6], similar time-dependent and concentration-dependent ac-
tivation of three MAPK subfamilies were revealed in our re-
sults. These di¡erences may be due to the di¡erent cell lines
and di¡erent extracellular stimuli used in each experiment, as
well as di¡erent upstream processes involved, such as RTK,
and PKC or PKA, in di¡erent reactions.
One characteristic of a non-genomic e¡ect is the short time-
lag of action. Our ¢ndings indicated that B could induce the
phosphorylation of p38 and JNK even in 5 min. Further-
more; the e¡ect was not a¡ected by RU38486, the antagonist
of classical nuclear glucocorticoid receptor. In addition, B-
BSA could also lead to the activation of p38 and JNK. Since
this compound is practically membrane impermeable, these
results supported the notion that B might act via putative
glucocorticoid membrane receptors. In mammalian cells, a
single receptor type can activate di¡erent MAPK pathways.
Phosphorylation of the RTKs, such as NGF receptor [16,17],
leads to the activation of small G proteins of the Ras and Rho
family. While Ras can activate the Raf/MEK/Erk pathway,
cdc42 and Rac, which belong to the Rho family, can mediate
the activation of p38 and JNK [9^11]. We examined the in-
volvement of RTK in the rapid steroid action. While genis-
tein, a RTK inhibitor, successfully blocked the NGF-induced
MAPK phosphorylation, it had no e¡ect on B-induced
MAPK activation. The ¢ndings implied that RTK activity is
Fig. 3. The e¡ect of SB203580 on B-induced p38 phosphorylation in
PC12 cells. Cells were incubated with or without B (1039 M) in the
presence or absence of the speci¢c inhibitor of p38, SB203580 (1035
M), and the agonist anisomycin (1035 M) for 15 min. The phos-
phorylation of p38 (parallel A upper) was determined by immuno-
blot. Parallel A lower represents total p38 using phospho-independ-
ent p38 MAPK. B: Quanti¢cation of p38 phosphorylation by
densitometry. Data are the means þ S.E.M. from three independent
experiments. **P6 0.01 compared with cells incubated with B alone.
##P6 0.01 compared with cells left untreated.
Fig. 4. The e¡ect of RU38486 on B-induced p38 and JNK phos-
phorylation in PC12 cells. Cells were incubated with B (1039 M), B-
BSA (1037 M) and BSA (1039 M) in the presence or absence of
glucocorticoid nuclear receptor antagonist, RU38486 (1036 M, 30
min) for 15 min. The phosphorylation of p38 (parallel A upper)
and JNK (parallel B upper) was determined by immunoblot. Paral-
lel A lower and parallel B lower represent total p38 and total JNK
using phospho-independent MAPK antibody, respectively.
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not involved in the responses via the putative glucocorticoid
membrane receptor.
In the present study, treatment of PMA could induce the
rapid activation of p38 and JNK. But Go«6976, a speci¢c in-
hibitor of PKCK and PKCL, could block the rapid action
induced by B. Since there is no PKCL in PC12 cells [18],
the results indicated that PKCK might mediate the rapid acti-
vation of the MAPK family elicited by B. Our previous work
found that B or B-BSA had no e¡ect on either the resting or
forskolin-stimulated cAMP level and PKA activities [8]. Thus,
the B-stimulated phosphorylation of p38 and JNK might in-
volve the PKC pathway, while the PKA pathway played no
part. It is interesting to observe whether the non-di¡erential
activation of Erk, p38 and JNK is a feature characteristic of
PKC activity in MAPK activation [8].
None of the single MAPK pathway is activated in response
to stimuli. Some investigation shows the crosstalk between the
speci¢c MAPKs; for instance, MEKK1, the Erk1 kinase ki-
nase, is capable of regulating the JNK and p38-induced NFUB
pathway. Some downstream substrates of the MAPKs are the
upstream of their own or other MAPKs. The relevance of the
rapid activation of MAPKs by steroid hormone is poorly
understood, but the activated MAPKs may translocate to
the nucleus to in£uence gene expression [21]. This raises the
assumption that a delayed e¡ect occurred after the rapid ac-
tion of steroids (Fig. 7), which may be a supplement to the
classical genomic e¡ect of steroid hormone through the clas-
sical nuclear receptor.
However, activation patterns of the MAPK family members
are complex. Recent evidence showed that transforming
growth factor L-activated kinase 1 (TAK1), a member of
the MAPK kinase kinase superfamily, acted as a link in the
delayed response to mechanical stress to phosphorylate p38
MAPK in vivo which elicits myocardial hypertrophy and ful-
minant heart failure [22]. TAK1 also participated in the JNK
signaling pathway during Drosophila development to control
the cell shape and regulation of apoptosis [23]. Whether
TAK1 is involved in the responses described in the present
study needs further investigation.
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